Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:34430609

Evaluation of the roles and regulatory mechanisms of PD-1 target molecules in NSCLC progression.

Yun-Qiang Zhang · Ye Yuan · Jun Zhang · Cheng-Yi Lin · Jia-Long Guo · Hua-Song Liu · Qiang Guo

Annals of translational medicine · 2021 doi:10.21037/atm-21-2963

Paper

complete

Experiment

complete

Data

partial

Analysis

complete

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:34430609
kind
science-record
content_hash
sha256:507929f5d639f9a6f6a1c496de4544003795ec9c1eb4e0101c32be8bf22fae05
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T15:41:49Z
updated_at
2026-11-01T22:04:33Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
Evaluation of the roles and regulatory mechanisms of PD-1 target molecules in NSCLC progression.
doi
10.21037/atm-21-2963
pmid
34430609
authors array · 7 items
[0]
Yun-Qiang Zhang
[1]
Ye Yuan
[2]
Jun Zhang
[3]
Cheng-Yi Lin
[4]
Jia-Long Guo
[5]
Hua-Song Liu
[6]
Qiang Guo
journal
Annals of translational medicine
year
2021
abstract
BACKGROUND: Targeted programmed cell death protein 1 (PD-1) therapy could effectively improve the long-term prognosis of patients with non-small cell lung cancer (NSCLC). The role of PD-1 targets in the progression of NSCLC has not been fully revealed. METHODS: The differentially expressed genes (DEGs) in patients' blood after NSCLC treatment with PD-1 blocker nivolumab in the GSE141479 dataset were analyzed by GEO2R and identified in the TCGA database. The mechanism of action involved in the PD-1 target molecules via the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). The protein-protein interaction (PPI) network shows the relationship between PD-1 target molecules. The factors affecting the prognosis of NSCLC patients were identified via the COX regression analysis and survival analysis to build the risk model and nomogram. RESULTS: There were 64 DEGs in patients' blood after nivolumab treatment and 48 DEGs in NSCLC tissues. The PD-1 target molecules involved cell proliferation, DNA replication, cell cycle, lung cancer, and other cellular processes. The prognostic factors CCNA2, CHEK1, DLGAP5, E2F8, FOXM1, HIST1H2BH, HJURP, MKI67, PLK1, TPX2, and TYMS, and the independent factors HIST1H2BH and PLK1, influenced the prognosis of NSCLC patients. HIST1H2BH and PLK1 were overexpressed in LUAD and LUSC tissues. The elevated expression levels of HIST1H2BH and PLK1 were related to the overall survival (OS) and the progression-free survival of NSCLC patients. High-risk NSCLC patients had a poor prognosis and were an independent factor influencing the poor prognosis of NSCLC patients. The high-risk model group was enriched with signaling mechanisms such as cell cycle, DNA replication, and homologous recombination. CONCLUSIONS: The risk model based on PD-1 target molecules was helpful to assess the prognosis of NSCLC patients. HIST1H2BH and PLK1 might become prognostic biomarkers of NSCLC patients.
claims array · 2 items
[0] object · 6 fields
id
claim-method
statement
K-M survival analysis showed that high-risk NSCLC patients in the risk model had poor prognoses (Figure 9A).
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:34430609
locator
sections[21] "Evaluation of the risk model in the prognosis of NSCLC patients" paragraph 2
quote
K-M survival analysis showed that high-risk NSCLC patients in the risk model had poor prognoses (Figure 9A).
state
complete
[1] object · 6 fields
id
claim-data-access
statement
The GSE141479 dataset of the Gene Expression Omnibus [GEO (http://www.ncbi.nlm.nih.gov/geo/)] database contained gene expression data from the blood samples of 74 NSCLC patients. Among them, 33 NSCLC patients were the blood samples treated with PD-1 inhibitor nivolumab.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:34430609
locator
sections[3] "GSE141479 dataset" paragraph 2
quote
The GSE141479 dataset of the Gene Expression Omnibus [GEO (http://www.ncbi.nlm.nih.gov/geo/)] database contained gene expression data from the blood samples of 74 NSCLC patients. Among them, 33 NSCLC patients were the blood samples treated with PD-1 inhibitor nivolumab.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
complete
objective
null
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:34430609
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
complete
blocked_on
null
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE141479
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE141479
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 0 items
data object · 3 fields
state
partial
assets array · 10 items
[0] object · 15 fields
id
source:pmid:34430609
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.21037/atm-21-2963
sha256
sha256:7c09d90cca004d875918fd5659a829235d980adde13b141df4ab22040e325c11
bytes
36052
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.21037/atm-21-2963
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC8350711
source
europe_pmc_fulltext
coverage
whole_body
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:GSE141479
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE141479
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE141479
version
null
note
The GSE141479 dataset of the Gene Expression Omnibus [GEO (http://www.ncbi.nlm.nih.gov/geo/)] database contained gene expression data from the blood samples of 74 NSCLC patients. Among them, 33 NSCLC patients were the blood samples treated with PD-1 inhibitor nivolumab.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
The GSE141479 dataset of the Gene Expression Omnibus [GEO (http://www.ncbi.nlm.nih.gov/geo/)] database contained gene expression data from the blood samples of 74 NSCLC patients. Among them, 33 NSCLC patients were the blood samples treated with PD-1 inhibitor nivolumab.
access_statement_kind
repository_route_statement
sample_accessions array · 74 items
[0]
GSM4204391
[1]
GSM4204392
[2]
GSM4204393
[3]
GSM4204394
[4]
GSM4204395
[5]
GSM4204396
[6]
GSM4204397
[7]
GSM4204398
[8]
GSM4204399
[9]
GSM4204400
[10]
GSM4204401
[11]
GSM4204402
[12]
GSM4204403
[13]
GSM4204404
[14]
GSM4204405
[15]
GSM4204406
[16]
GSM4204407
[17]
GSM4204408
[18]
GSM4204409
[19]
GSM4204410
[20]
GSM4204411
[21]
GSM4204412
[22]
GSM4204413
[23]
GSM4204414
[24]
GSM4204415
[25]
GSM4204416
[26]
GSM4204417
[27]
GSM4204418
[28]
GSM4204419
[29]
GSM4204420
[30]
GSM4204421
[31]
GSM4204422
[32]
GSM4204423
[33]
GSM4204424
[34]
GSM4204425
[35]
GSM4204426
[36]
GSM4204427
[37]
GSM4204428
[38]
GSM4204429
[39]
GSM4204430
[40]
GSM4204431
[41]
GSM4204432
[42]
GSM4204433
[43]
GSM4204434
[44]
GSM4204435
[45]
GSM4204436
[46]
GSM4204437
[47]
GSM4204438
[48]
GSM4204439
[49]
GSM4204440
[50]
GSM4204441
[51]
GSM4204442
[52]
GSM4204443
[53]
GSM4204444
[54]
GSM4204445
[55]
GSM4204446
[56]
GSM4204447
[57]
GSM4204448
[58]
GSM4204449
[59]
GSM4204450
[60]
GSM4204451
[61]
GSM4204452
[62]
GSM4204453
[63]
GSM4204454
[64]
GSM4204455
[65]
GSM4204456
[66]
GSM4204457
[67]
GSM4204458
[68]
GSM4204459
[69]
GSM4204460
[70]
GSM4204461
[71]
GSM4204462
[72]
GSM4204463
[73]
GSM4204464
sample_count
74
group_sizes
null
group_sizes_basis
null
platform
23126
taxon
Homo sapiens
title
Combination of host immune metabolic biomarkers for the PD-1 blockade cancer immunotherapy
resolution_checked_at
2026-11-01T15:39:54Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[2] object · 16 fields
id
asset:table:pmid:34430609:1
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:418f6f0db116832722a0eed0ee0675c4eff5fb0a9e96cb50a3eb48a8d93bb6eb
bytes
2754
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[16]/table-wrap[1]#t1
version
null
note
The expression level of PD-1 target molecules in GSE141479 NSCLC blood samples
structure object · 5 fields
pmcid
PMC8350711
section_index
16
section_title
The expression levels of PD-1 target molecules in NSCLC
row_count
65
column_count
3
table object · 8 fields
label
Table 1
caption
The expression level of PD-1 target molecules in GSE141479 NSCLC blood samples
rows array · 65 items
[0] array · 3 items
[0]
Gene
[1]
P
[2]
logFC
[1] array · 3 items
[0]
SNORD111
[1]
0.00493817
[2]
0.72559394
[2] array · 3 items
[0]
RNU6-948P
[1]
0.03444443
[2]
0.69960397
[3] array · 3 items
[0]
KCNQ1OT1_5
[1]
0.00166819
[2]
0.68030422
[4] array · 3 items
[0]
LEF1-AS1
[1]
0.03273117
[2]
0.65527865
[5] array · 3 items
[0]
SNORD63
[1]
0.00920666
[2]
0.64174079
[6] array · 3 items
[0]
GPRASP1
[1]
0.00110561
[2]
0.63013588
[7] array · 3 items
[0]
HMGB3P4
[1]
0.00121729
[2]
0.61194145
[8] array · 3 items
[0]
MTCO1P31
[1]
0.02050908
[2]
0.60380088
[9] array · 3 items
[0]
ARHGAP17
[1]
0.0023222
[2]
0.603064
[10] array · 3 items
[0]
CUBN
[1]
0.01017528
[2]
0.59152504
[11] array · 3 items
[0]
TRAJ14
[1]
0.002776
[2]
0.58637359
[12] array · 3 items
[0]
CDCA2
[1]
0.01072148
[2]
−0.59144421
[13] array · 3 items
[0]
FAM83D
[1]
0.00157576
[2]
−0.59256397
[14] array · 3 items
[0]
FOXM1
[1]
0.01552184
[2]
−0.59382417
[15] array · 3 items
[0]
H2BFS
[1]
0.00312788
[2]
−0.6007239
[16] array · 3 items
[0]
KIF11
[1]
0.01282965
[2]
−0.60308543
[17] array · 3 items
[0]
CENPU
[1]
0.00655007
[2]
−0.6075029
[18] array · 3 items
[0]
MLC1
[1]
0.03826616
[2]
−0.60756707
[19] array · 3 items
[0]
NUSAP1
[1]
0.00545245
[2]
−0.61177406
[20] array · 3 items
[0]
SGOL1
[1]
0.00965143
[2]
−0.61373539
[21] array · 3 items
[0]
MCM2
[1]
0.00100469
[2]
−0.61971768
[22] array · 3 items
[0]
CDC6
[1]
0.02287365
[2]
−0.62300489
[23] array · 3 items
[0]
KIF20A
[1]
0.01558623
[2]
−0.62524289
[24] array · 3 items
[0]
GMNN
[1]
0.00932813
[2]
−0.6271711
[25] array · 3 items
[0]
CENPM
[1]
0.00565937
[2]
−0.6351112
[26] array · 3 items
[0]
RFC2
[1]
0.00022004
[2]
−0.63632544
[27] array · 3 items
[0]
CENPN
[1]
0.00127519
[2]
−0.63697021
[28] array · 3 items
[0]
BRCA2
[1]
0.00532567
[2]
−0.64152522
[29] array · 3 items
[0]
E2F8
[1]
0.03568498
[2]
−0.64326644
[30] array · 3 items
[0]
EXO1
[1]
0.00176873
[2]
−0.65220136
[31] array · 3 items
[0]
HIST1H2BI
[1]
0.00253962
[2]
−0.65270249
[32] array · 3 items
[0]
HIST1H2BJ
[1]
0.00212488
[2]
−0.65351784
[33] array · 3 items
[0]
PLK1
[1]
0.02763867
[2]
−0.65474106
[34] array · 3 items
[0]
DTL
[1]
0.03959844
[2]
−0.65616881
[35] array · 3 items
[0]
HIST1H2BK
[1]
0.00185741
[2]
−0.65692162
[36] array · 3 items
[0]
CENPF
[1]
0.01276753
[2]
−0.67133204
[37] array · 3 items
[0]
CDKN3
[1]
0.03077191
[2]
−0.6757393
[38] array · 3 items
[0]
HIST1H2BH
[1]
0.0023265
[2]
−0.67885224
[39] array · 3 items
[0]
CKS2
[1]
0.00375082
[2]
−0.69673774
[40] array · 3 items
[0]
PRRG4
[1]
0.00719681
[2]
−0.70325329
[41] array · 3 items
[0]
HJURP
[1]
0.00669842
[2]
−0.70537786
[42] array · 3 items
[0]
STMN1
[1]
0.00217296
[2]
−0.70766827
[43] array · 3 items
[0]
PRC1
[1]
0.00168319
[2]
−0.7179418
[44] array · 3 items
[0]
CCNB2
[1]
0.03641449
[2]
−0.71887783
[45] array · 3 items
[0]
NDC80
[1]
0.00073926
[2]
−0.72614622
[46] array · 3 items
[0]
TPX2
[1]
0.01299743
[2]
−0.74730387
[47] array · 3 items
[0]
KIF15
[1]
0.00218344
[2]
−0.74827382
[48] array · 3 items
[0]
HIST1H2BL
[1]
0.00364301
[2]
−0.7494745
[49] array · 3 items
[0]
RAD51AP1
[1]
0.00063054
[2]
−0.7701625
[50] array · 3 items
[0]
HIST1H3B
[1]
0.00397439
[2]
−0.78280432
[51] array · 3 items
[0]
CCNA2
[1]
0.02322892
[2]
−0.79709647
[52] array · 3 items
[0]
CD38
[1]
0.01137765
[2]
−0.79908712
[53] array · 3 items
[0]
HIST1H2BB
[1]
0.00085693
[2]
−0.80144284
[54] array · 3 items
[0]
HIST1H1B
[1]
0.00378843
[2]
−0.80473676
[55] array · 3 items
[0]
CENPW
[1]
0.00594784
[2]
−0.80853294
[56] array · 3 items
[0]
TYMS
[1]
0.01973621
[2]
−0.81167961
[57] array · 3 items
[0]
TOP2A
[1]
0.00627913
[2]
−0.84272863
[58] array · 3 items
[0]
HIST1H2BM
[1]
0.01649506
[2]
−0.88164367
[59] array · 3 items
[0]
DLGAP5
[1]
0.03435208
[2]
−0.90377947
[60] array · 3 items
[0]
CHEK1
[1]
0.00301191
[2]
−0.92741563
[61] array · 3 items
[0]
MELK
[1]
0.0003221
[2]
−0.93779218
[62] array · 3 items
[0]
FAM111B
[1]
0.00026547
[2]
−0.97286209
[63] array · 3 items
[0]
MKI67
[1]
0.00484638
[2]
−0.99910995
[64] array · 3 items
[0]
KIAA0101
[1]
0.00937747
[2]
−1.04596747
locator
section[16]/table-wrap[1]#t1
[3] object · 16 fields
id
asset:table:pmid:34430609:2
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:751ce406af621c2334dda96ea6d76f2d93fe3631e6cc9cb917009e143ef3eb38
bytes
1939
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[16]/table-wrap[2]#t2
version
null
note
The expression levels of PD-1 target molecules in NSCLC tissues
structure object · 5 fields
pmcid
PMC8350711
section_index
16
section_title
The expression levels of PD-1 target molecules in NSCLC
row_count
49
column_count
3
table object · 8 fields
label
Table 2
caption
The expression levels of PD-1 target molecules in NSCLC tissues
rows array · 49 items
[0] array · 3 items
[0]
Gene
[1]
logFC
[2]
P
[1] array · 3 items
[0]
HIST1H3B
[1]
6.971563358
[2]
5.22E-42
[2] array · 3 items
[0]
HIST1H1B
[1]
6.889830378
[2]
1.98E-34
[3] array · 3 items
[0]
HIST1H2BB
[1]
6.6176645
[2]
2.92E-16
[4] array · 3 items
[0]
HIST1H2BM
[1]
6.546656387
[2]
1.70E-27
[5] array · 3 items
[0]
HIST1H2BI
[1]
6.144328211
[2]
3.81E-19
[6] array · 3 items
[0]
HIST1H2BH
[1]
5.25752465
[2]
1.97E-39
[7] array · 3 items
[0]
HJURP
[1]
4.423193962
[2]
9.76E-63
[8] array · 3 items
[0]
TPX2
[1]
4.356893524
[2]
1.49E-61
[9] array · 3 items
[0]
MELK
[1]
4.28293495
[2]
2.60E-61
[10] array · 3 items
[0]
TOP2A
[1]
4.239513136
[2]
6.71E-63
[11] array · 3 items
[0]
FOXM1
[1]
4.206146682
[2]
1.40E-60
[12] array · 3 items
[0]
EXO1
[1]
4.176032779
[2]
4.79E-62
[13] array · 3 items
[0]
DLGAP5
[1]
4.123032333
[2]
1.54E-61
[14] array · 3 items
[0]
CENPF
[1]
4.004101702
[2]
2.23E-61
[15] array · 3 items
[0]
CDC6
[1]
3.962775113
[2]
8.09E-62
[16] array · 3 items
[0]
PLK1
[1]
3.804871556
[2]
1.14E-62
[17] array · 3 items
[0]
CCNB2
[1]
3.791913823
[2]
1.42E-61
[18] array · 3 items
[0]
HIST1H2BL
[1]
3.771763049
[2]
4.85E-33
[19] array · 3 items
[0]
NDC80
[1]
3.66052765
[2]
1.20E-60
[20] array · 3 items
[0]
CDCA2
[1]
3.618670951
[2]
2.97E-60
[21] array · 3 items
[0]
KIF20A
[1]
3.560206265
[2]
2.46E-61
[22] array · 3 items
[0]
CCNA2
[1]
3.560063035
[2]
9.08E-61
[23] array · 3 items
[0]
MKI67
[1]
3.512151918
[2]
2.23E-58
[24] array · 3 items
[0]
CDKN3
[1]
3.434927857
[2]
1.04E-57
[25] array · 3 items
[0]
FAM83D
[1]
3.412001161
[2]
2.99E-50
[26] array · 3 items
[0]
E2F8
[1]
3.334165686
[2]
2.05E-61
[27] array · 3 items
[0]
PRC1
[1]
3.322365587
[2]
1.58E-61
[28] array · 3 items
[0]
KIF11
[1]
3.262694147
[2]
7.05E-62
[29] array · 3 items
[0]
NUSAP1
[1]
3.233047006
[2]
1.10E-60
[30] array · 3 items
[0]
KIF15
[1]
3.110763871
[2]
7.51E-59
[31] array · 3 items
[0]
FAM111B
[1]
3.110199706
[2]
4.99E-57
[32] array · 3 items
[0]
MCM2
[1]
2.988886147
[2]
5.17E-58
[33] array · 3 items
[0]
CENPU
[1]
2.922017757
[2]
3.96E-59
[34] array · 3 items
[0]
RAD51AP1
[1]
2.910137622
[2]
4.25E-55
[35] array · 3 items
[0]
CHEK1
[1]
2.741114388
[2]
2.08E-61
[36] array · 3 items
[0]
HIST1H2BJ
[1]
2.624552264
[2]
7.72E-28
[37] array · 3 items
[0]
CENPM
[1]
2.594186936
[2]
9.10E-51
[38] array · 3 items
[0]
CENPW
[1]
2.583310716
[2]
1.63E-42
[39] array · 3 items
[0]
DTL
[1]
2.466385804
[2]
3.72E-50
[40] array · 3 items
[0]
TYMS
[1]
2.401391345
[2]
4.02E-56
[41] array · 3 items
[0]
GMNN
[1]
1.900079663
[2]
1.15E-56
[42] array · 3 items
[0]
CENPN
[1]
1.899039582
[2]
1.93E-47
[43] array · 3 items
[0]
STMN1
[1]
1.625279048
[2]
2.36E-35
[44] array · 3 items
[0]
CKS2
[1]
1.53273206
[2]
6.79E-34
[45] array · 3 items
[0]
BRCA2
[1]
1.461967704
[2]
6.31E-37
[46] array · 3 items
[0]
HIST1H2BK
[1]
1.422823205
[2]
4.16E-26
[47] array · 3 items
[0]
RFC2
[1]
1.239427886
[2]
1.96E-48
[48] array · 3 items
[0]
H2BFS
[1]
1.214789768
[2]
0.02134121
locator
section[16]/table-wrap[2]#t2
[4] object · 16 fields
id
asset:table:pmid:34430609:3
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:9d55452b93c1081be26b57a41526dc6f68562059aac94b93e1069b8159058ab3
bytes
1097
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[17]/table-wrap[1]#t3
version
null
note
Disease related to PD-1 target molecules
structure object · 5 fields
pmcid
PMC8350711
section_index
17
section_title
The biological functions and signaling mechanisms of PD-1 target molecules
row_count
16
column_count
4
table object · 8 fields
label
Table 3
caption
Disease related to PD-1 target molecules
rows array · 16 items
[0] array · 4 items
[0]
Category
[1]
Term
[2]
Count
[3]
P
[1] array · 4 items
[0]
GAD_DISEASE
[1]
Breast Cancer
[2]
10
[3]
2.72E-05
[2] array · 4 items
[0]
GAD_DISEASE
[1]
Longevity
[2]
9
[3]
1.68E-05
[3] array · 4 items
[0]
GAD_DISEASE
[1]
Chronic renal failure|Kidney Failure, Chronic
[2]
8
[3]
0.011029875
[4] array · 4 items
[0]
GAD_DISEASE
[1]
Ovarian cancer
[2]
7
[3]
4.88E-04
[5] array · 4 items
[0]
GAD_DISEASE
[1]
Breast cancer
[2]
7
[3]
0.002764474
[6] array · 4 items
[0]
GAD_DISEASE
[1]
Bladder Cancer
[2]
7
[3]
0.003069375
[7] array · 4 items
[0]
GAD_DISEASE
[1]
Chronic obstructive pulmonary disease
[2]
6
[3]
0.005391657
[8] array · 4 items
[0]
GAD_DISEASE
[1]
Lung cancer
[2]
6
[3]
0.013295264
[9] array · 4 items
[0]
GAD_DISEASE
[1]
Lung Cancer
[2]
6
[3]
0.022918521
[10] array · 4 items
[0]
GAD_DISEASE
[1]
Leukemia, Lymphocytic, Chronic, B-Cell
[2]
5
[3]
0.002712277
[11] array · 4 items
[0]
GAD_DISEASE
[1]
Esophageal adenocarcinoma
[2]
5
[3]
0.015692824
[12] array · 4 items
[0]
GAD_DISEASE
[1]
Pharmacogenetic studies
[2]
4
[3]
0.003197262
[13] array · 4 items
[0]
GAD_DISEASE
[1]
Adenocarcinoma|Pancreatic Neoplasms
[2]
3
[3]
0.009443208
[14] array · 4 items
[0]
GAD_DISEASE
[1]
Head and neck cancer
[2]
3
[3]
0.026277742
[15] array · 4 items
[0]
GAD_DISEASE
[1]
Abortion, Spontaneous
[2]
3
[3]
0.036618707
locator
section[17]/table-wrap[1]#t3
[5] object · 16 fields
id
asset:table:pmid:34430609:4
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:f316443394dda384ff62d443ad58c7d8ed955b25d2427e266d7a65de5da3acc3
bytes
990
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[19]/table-wrap[1]#t4
version
null
note
Univariate Cox regression analysis showed the prognostic factors of NSCLC patients
structure object · 5 fields
pmcid
PMC8350711
section_index
19
section_title
Construction of PD-1 target molecular risk model
row_count
12
column_count
5
table object · 8 fields
label
Table 4
caption
Univariate Cox regression analysis showed the prognostic factors of NSCLC patients
rows array · 12 items
[0] array · 5 items
[0]
Gene
[1]
HR
[2]
HR.95L
[3]
HR.95H
[4]
P
[1] array · 5 items
[0]
CCNA2
[1]
1.119030214
[2]
1.015250316
[3]
1.233418597
[4]
0.023527732
[2] array · 5 items
[0]
CHEK1
[1]
1.161268534
[2]
1.003467151
[3]
1.343885155
[4]
0.044812367
[3] array · 5 items
[0]
DLGAP5
[1]
1.120187116
[2]
1.007468832
[3]
1.24551662
[4]
0.035951079
[4] array · 5 items
[0]
E2F8
[1]
1.188481809
[2]
1.015445446
[3]
1.391004328
[4]
0.031485368
[5] array · 5 items
[0]
FOXM1
[1]
1.105655354
[2]
1.017333811
[3]
1.20164468
[4]
0.018052236
[6] array · 5 items
[0]
HIST1H2BH
[1]
0.896796742
[2]
0.827448404
[3]
0.971957155
[4]
0.007986484
[7] array · 5 items
[0]
HJURP
[1]
1.113339724
[2]
1.001826182
[3]
1.237265867
[4]
0.046168795
[8] array · 5 items
[0]
MKI67
[1]
1.118363726
[2]
1.008411159
[3]
1.24030502
[4]
0.034124878
[9] array · 5 items
[0]
PLK1
[1]
1.184761851
[2]
1.061018977
[3]
1.322936416
[4]
0.002592543
[10] array · 5 items
[0]
TPX2
[1]
1.102047152
[2]
1.014411384
[3]
1.19725384
[4]
0.021538305
[11] array · 5 items
[0]
TYMS
[1]
1.146977658
[2]
1.026076189
[3]
1.282124819
[4]
0.015825538
locator
section[19]/table-wrap[1]#t4
[6] object · 16 fields
id
asset:table:pmid:34430609:5
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:3500238a2742189de98230e4635205d52276d2603ce4f62c1da1af8bc4319427
bytes
403
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[19]/table-wrap[2]#t5
version
null
note
The independent prognostic factors of NSCLC patients
structure object · 5 fields
pmcid
PMC8350711
section_index
19
section_title
Construction of PD-1 target molecular risk model
row_count
3
column_count
6
table object · 8 fields
label
Table 5
caption
The independent prognostic factors of NSCLC patients
rows array · 3 items
[0] array · 6 items
[0]
Gene
[1]
coef
[2]
HR
[3]
HR.95L
[4]
HR.95H
[5]
P
[1] array · 6 items
[0]
HIST1H2BH
[1]
−0.220239949
[2]
0.802326258
[3]
0.729774307
[4]
0.882091103
[5]
5.25E-06
[2] array · 6 items
[0]
PLK1
[1]
0.303398284
[2]
1.354453815
[3]
1.199191723
[4]
1.529818043
[5]
1.04E-06
locator
section[19]/table-wrap[2]#t5
[7] object · 16 fields
id
asset:table:pmid:34430609:6
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:001b05e6b8c81c16c0b6330baa20e6eedfa5462362b69cb653a7da872dea8d52
bytes
2043
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[20]/table-wrap[1]#t6
version
null
note
The value of risk model factors in LUAD
structure object · 5 fields
pmcid
PMC8350711
section_index
20
section_title
The value of risk model factors was verified in NSCLC
row_count
33
column_count
4
table object · 8 fields
label
Table 6
caption
The value of risk model factors in LUAD
rows array · 33 items
[0] array · 4 items
[0]
Clinical features
[1]
Type
[2]
HIST1H2BH
[3]
PLK1
[1] array · 4 items
[0]
Gender
[1]
Male vs. female
[2]
4.84E-03
[3]
1.47E-02
[2] array · 4 items
[0]
Age
[1]
Age (21–40 years) vs. age (81–100 years)
[2]
1.59E-02
[3]
NS
[3] array · 4 items
[0]
[1]
Age (41–60 years) vs. age (61–80 years)
[2]
NS
[3]
1.91E-02
[4] array · 4 items
[0]
[1]
Age (41–60 years) vs. age (81–100 years)
[2]
1.04E-04
[3]
NS
[5] array · 4 items
[0]
[1]
Age (61–80 years) vs. age (81–100 years)
[2]
4.98E-03
[3]
NS
[6] array · 4 items
[0]
Smoking
[1]
Non smoker vs. smoker
[2]
4.77E-04
[3]
1.89E-05
[7] array · 4 items
[0]
[1]
Non smoker vs. reformed smoker2
[2]
4.60E-03
[3]
1.86E-03
[8] array · 4 items
[0]
[1]
Smoker vs. reformed smoker1
[2]
3.08E-03
[3]
2.84E-08
[9] array · 4 items
[0]
[1]
Reformed smoker1 vs. reformed smoker2
[2]
2.58E-02
[3]
1.50E-06
[10] array · 4 items
[0]
Clinical stage
[1]
Stage1 vs. Stage3
[2]
NS
[3]
4.15E-02
[11] array · 4 items
[0]
[1]
Stage1 vs. Stage4
[2]
NS
[3]
9.74E-03
[12] array · 4 items
[0]
Tissue type
[1]
NOS vs. mixed
[2]
7.16E-03
[3]
2.22E-03
[13] array · 4 items
[0]
[1]
NOS vs. LBC-NonMucinous
[2]
3.45E-07
[3]
1.10E-07
[14] array · 4 items
[0]
[1]
NOS vs. LBC-Mucinous
[2]
NS
[3]
5.93E-10
[15] array · 4 items
[0]
[1]
NOS vs. mucinous carcinoma
[2]
2.41E-04
[3]
2.18E-02
[16] array · 4 items
[0]
[1]
NOS vs. papillary
[2]
9.73E-07
[3]
NS
[17] array · 4 items
[0]
[1]
NOS vs. micropapillary
[2]
7.48E-12
[3]
NS
[18] array · 4 items
[0]
[1]
Mixed vs. LBC-NonMucinous
[2]
4.96E-03
[3]
2.56E-03
[19] array · 4 items
[0]
[1]
Mixed vs. SolidPatternPredominant
[2]
1.84E-03
[3]
4.67E-02
[20] array · 4 items
[0]
[1]
Mixed vs. LBC-Mucinous
[2]
NS
[3]
2.09E-07
[21] array · 4 items
[0]
[1]
Mixed vs. papillary
[2]
1.25E-02
[3]
NS
[22] array · 4 items
[0]
[1]
Mixed vs. micropapillary
[2]
4.82E-07
[3]
NS
[23] array · 4 items
[0]
[1]
LBC-NonMucinous vs. SolidPatternPredominant
[2]
NS
[3]
9.71E-05
[24] array · 4 items
[0]
[1]
LBC-NonMucinous vs. acinar
[2]
NS
[3]
2.24E-02
[25] array · 4 items
[0]
[1]
LBC-NonMucinous vs. LBC-Mucinous
[2]
NS
[3]
4.67E-02
[26] array · 4 items
[0]
[1]
SolidPatternPredominant vs. LBC-Mucinous
[2]
NS
[3]
1.51E-02
[27] array · 4 items
[0]
[1]
SolidPatternPredominant vs. mucinous carcinoma
[2]
NS
[3]
1.48E-02
[28] array · 4 items
[0]
[1]
SolidPatternPredominant vs. micropapillary
[2]
4.57E-02
[3]
NS
[29] array · 4 items
[0]
[1]
Acinar vs. LBC-Mucinous
[2]
NS
[3]
8.57E-04
[30] array · 4 items
[0]
[1]
LBC-Mucinous vs. mucinous carcinoma
[2]
NS
[3]
2.79E-02
[31] array · 4 items
[0]
[1]
LBC-Mucinous vs. papillary
[2]
NS
[3]
1.09E-02
[32] array · 4 items
[0]
TP53 Mutant
[1]
TP53-Mutant vs. TP53-NonMutant
[2]
NS
[3]
9.91E-12
locator
section[20]/table-wrap[1]#t6
[8] object · 16 fields
id
asset:table:pmid:34430609:7
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:25d649a8346280f01713c9e83d5177c5b89faf6e686b053f8c38688030ffdecc
bytes
1030
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[20]/table-wrap[2]#t7
version
null
note
The value of risk model factors in LUSC
structure object · 5 fields
pmcid
PMC8350711
section_index
20
section_title
The value of risk model factors was verified in NSCLC
row_count
16
column_count
4
table object · 8 fields
label
Table 7
caption
The value of risk model factors in LUSC
rows array · 16 items
[0] array · 4 items
[0]
Clinical features
[1]
Type
[2]
HIST1H2BH
[3]
PLK1
[1] array · 4 items
[0]
LUSC
[1]
Normal vs. primary
[2]
<1E-12
[3]
<1E-12
[2] array · 4 items
[0]
Gender
[1]
Male vs. female
[2]
NS
[3]
4.31E-02
[3] array · 4 items
[0]
Age
[1]
Age (41–60 years) vs. age (61–80 years)
[2]
NS
[3]
1.41E-02
[4] array · 4 items
[0]
[1]
Age (41–60 years) vs. age (81–100 years)
[2]
NS
[3]
2.34E-03
[5] array · 4 items
[0]
Smoking
[1]
Non smoker vs. smoker
[2]
1.84E-05
[3]
NS
[6] array · 4 items
[0]
[1]
Non smoker vs. reformed smoker1
[2]
1.04E-03
[3]
NS
[7] array · 4 items
[0]
[1]
Non smoker vs. reformed smoker2
[2]
3.15E-06
[3]
NS
[8] array · 4 items
[0]
[1]
Smoker vs. reformed smoker1
[2]
NS
[3]
1.02E-02
[9] array · 4 items
[0]
[1]
Reformed smoker1 vs. reformed smoker2
[2]
NS
[3]
3.68E-02
[10] array · 4 items
[0]
Clinical stage
[1]
Stage1 vs. Stage3
[2]
NS
[3]
2.90E-02
[11] array · 4 items
[0]
[1]
Stage3 vs. Stage4
[2]
NS
[3]
2.70E-02
[12] array · 4 items
[0]
[1]
NOS vs. papillary
[2]
1.68E-03
[3]
NS
[13] array · 4 items
[0]
Lymph node metastasis
[1]
N0 vs. N1
[2]
NS
[3]
6.36E-03
[14] array · 4 items
[0]
[1]
N0 vs. N2
[2]
NS
[3]
1.32E-02
[15] array · 4 items
[0]
TP53 Mutant
[1]
TP53-Mutant vs. TP53-NonMutant
[2]
NS
[3]
2.68E-03
locator
section[20]/table-wrap[2]#t7
[9] object · 16 fields
id
asset:table:pmid:34430609:8
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:0c0a44f19a3d2d66a552b0f5b5eb7bec98858f426b3cc4300d8a288e28b82f64
bytes
2373
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[22]/table-wrap[1]#t8
version
null
note
The signaling mechanisms involved in the high-risk group
structure object · 5 fields
pmcid
PMC8350711
section_index
22
section_title
The signaling mechanisms involved in the risk model
row_count
40
column_count
4
table object · 8 fields
label
Table 8
caption
The signaling mechanisms involved in the high-risk group
rows array · 40 items
[0] array · 4 items
[0]
Name
[1]
Size
[2]
NES
[3]
NOM P
[1] array · 4 items
[0]
CELL_CYCLE
[1]
124
[2]
2.3562934
[3]
0
[2] array · 4 items
[0]
MISMATCH_REPAIR
[1]
23
[2]
2.2620559
[3]
0
[3] array · 4 items
[0]
PROGESTERONE_MEDIATED_OOCYTE_MATURATION
[1]
85
[2]
2.2228281
[3]
0
[4] array · 4 items
[0]
OOCYTE_MEIOSIS
[1]
112
[2]
2.2174144
[3]
0
[5] array · 4 items
[0]
DNA_REPLICATION
[1]
36
[2]
2.209795
[3]
0
[6] array · 4 items
[0]
ONE_CARBON_POOL_BY_FOLATE
[1]
17
[2]
2.2025287
[3]
0
[7] array · 4 items
[0]
NUCLEOTIDE_EXCISION_REPAIR
[1]
44
[2]
2.1026423
[3]
0
[8] array · 4 items
[0]
HOMOLOGOUS_RECOMBINATION
[1]
28
[2]
2.09409
[3]
0
[9] array · 4 items
[0]
PATHOGENIC_ESCHERICHIA_COLI_INFECTION
[1]
55
[2]
2.0320096
[3]
0
[10] array · 4 items
[0]
PYRIMIDINE_METABOLISM
[1]
97
[2]
1.9931018
[3]
0
[11] array · 4 items
[0]
UBIQUITIN_MEDIATED_PROTEOLYSIS
[1]
133
[2]
1.9535059
[3]
0
[12] array · 4 items
[0]
CHRONIC_MYELOID_LEUKEMIA
[1]
73
[2]
1.909263
[3]
0.001972387
[13] array · 4 items
[0]
AMINOACYL_TRNA_BIOSYNTHESIS
[1]
22
[2]
1.9242635
[3]
0.001992032
[14] array · 4 items
[0]
PANCREATIC_CANCER
[1]
70
[2]
1.8818412
[3]
0.002008032
[15] array · 4 items
[0]
BASAL_TRANSCRIPTION_FACTORS
[1]
35
[2]
1.8217084
[3]
0.004008016
[16] array · 4 items
[0]
PROTEASOME
[1]
44
[2]
1.9331573
[3]
0.004040404
[17] array · 4 items
[0]
BASE_EXCISION_REPAIR
[1]
33
[2]
1.8571749
[3]
0.004166667
[18] array · 4 items
[0]
PENTOSE_PHOSPHATE_PATHWAY
[1]
27
[2]
1.8049825
[3]
0.007722008
[19] array · 4 items
[0]
P53_SIGNALING_PATHWAY
[1]
68
[2]
1.7388005
[3]
0.007843138
[20] array · 4 items
[0]
RNA_DEGRADATION
[1]
57
[2]
1.7536411
[3]
0.008
[21] array · 4 items
[0]
SPLICEOSOME
[1]
126
[2]
1.7790519
[3]
0.008064516
[22] array · 4 items
[0]
GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM
[1]
16
[2]
1.7177893
[3]
0.011904762
[23] array · 4 items
[0]
BLADDER_CANCER
[1]
42
[2]
1.5846695
[3]
0.016194332
[24] array · 4 items
[0]
PATHWAYS_IN_CANCER
[1]
325
[2]
1.5147824
[3]
0.016666668
[25] array · 4 items
[0]
GLIOMA
[1]
65
[2]
1.6071352
[3]
0.018108651
[26] array · 4 items
[0]
CITRATE_CYCLE_TCA_CYCLE
[1]
30
[2]
1.7157203
[3]
0.025590552
[27] array · 4 items
[0]
DEGRADATION
[1]
44
[2]
1.6497922
[3]
0.026859503
[28] array · 4 items
[0]
PURINE_METABOLISM
[1]
156
[2]
1.5934625
[3]
0.027139874
[29] array · 4 items
[0]
GAP_JUNCTION
[1]
89
[2]
1.5358167
[3]
0.027600849
[30] array · 4 items
[0]
PROSTATE_CANCER
[1]
89
[2]
1.5185701
[3]
0.030120483
[31] array · 4 items
[0]
DRUG_METABOLISM_OTHER_ENZYMES
[1]
51
[2]
1.5393608
[3]
0.031067962
[32] array · 4 items
[0]
THYROID_CANCER
[1]
29
[2]
1.5549417
[3]
0.032467533
[33] array · 4 items
[0]
SMALL_CELL_LUNG_CANCER
[1]
84
[2]
1.5911384
[3]
0.034836065
[34] array · 4 items
[0]
FRUCTOSE_AND_MANNOSE_METABOLISM
[1]
32
[2]
1.5649511
[3]
0.035363458
[35] array · 4 items
[0]
NON_SMALL_CELL_LUNG_CANCER
[1]
54
[2]
1.5211327
[3]
0.036885247
[36] array · 4 items
[0]
CYSTEINE_AND_METHIONINE_METABOLISM
[1]
34
[2]
1.4945567
[3]
0.03807615
[37] array · 4 items
[0]
AMYOTROPHIC_LATERAL_SCLEROSIS_ALS
[1]
52
[2]
1.4684905
[3]
0.038306452
[38] array · 4 items
[0]
N_GLYCAN_BIOSYNTHESIS
[1]
46
[2]
1.5310353
[3]
0.04761905
[39] array · 4 items
[0]
FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS
[1]
95
[2]
1.5192246
[3]
0.04897959
locator
section[22]/table-wrap[1]#t8
gaps array · 2 items
[0]
asset:data:geo:GSE141479 not downloaded
[1]
asset:data:geo:GSE141479 licence not read
analysis object · 4 fields
state
complete
methods array · 3 items
[0] object · 10 fields
id
method-1
family
survival_analysis
specific
kaplan_meier
label
Survival analysis
dsl_operations array · 1 item
[0]
survival_km
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
1
band
verbatim
quote
K-M survival analysis showed that high-risk NSCLC patients in the risk model had poor prognoses (Figure 9A).
[1] object · 10 fields
id
method-2
family
survival_analysis
specific
cox_proportional_hazards
label
Survival analysis
dsl_operations array · 1 item
[0]
cox_ph
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.7
band
medium
quote
COX regression
[2] object · 10 fields
id
method-3
family
network_analysis
specific
ppi_network
label
Network / pathway analysis
dsl_operations array · 3 items
[0]
build_graph
[1]
centrality_scores
[2]
pathway_enrich
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
edge_list
evidence object · 3 fields
score
0.7
band
medium
quote
protein-protein interaction
targets array · 0 items
gaps array · 0 items
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
complete
tier
R1
blocked_on
nothing:replicable_now
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
true
required_operations array · 1 item
[0]
survival_km
missing_operations array · 0 items
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: kaplan_meier.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R1
reachable
true
accessions array · 1 item
[0]
GSE141479
resolved_accessions array · 1 item
[0]
GSE141479
statements array · 1 item
[0]
The GSE141479 dataset of the Gene Expression Omnibus [GEO (http://www.ncbi.nlm.nih.gov/geo/)] database contained gene expression data from the blood samples of 74 NSCLC patients. Among them, 33 NSCLC patients were the blood samples treated with PD-1 inhibitor nivolumab.
basis
The paper names GSE141479 in Gene Expression Omnibus (GEO) and the accession resolves in the repository. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 1 item
[0]
survival_km
assets array · 10 items
[0]
source:pmid:34430609
[1]
data:geo:GSE141479
[2]
asset:table:pmid:34430609:1
[3]
asset:table:pmid:34430609:2
[4]
asset:table:pmid:34430609:3
[5]
asset:table:pmid:34430609:4
[6]
asset:table:pmid:34430609:5
[7]
asset:table:pmid:34430609:6
[8]
asset:table:pmid:34430609:7
[9]
asset:table:pmid:34430609:8
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:GSE141479
gaps array · 0 items
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-10-31T18:33:59Z
independence
single_reader
evidence_check object · 2 fields
method
verbatim
availability
null
calls
3
usage object · 3 fields
prompt_tokens
28823
completion_tokens
2330
cached_tokens
9736
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:34430609
type
paper
label
pmid:34430609
[1] object · 3 fields
id
source:pmid:34430609
type
manuscript
label
PMID 34430609 full text
[2] object · 3 fields
id
data:geo:GSE141479
type
dataset
label
GEO GSE141479
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:34430609
type
paper
label
pmid:34430609
[1] object · 3 fields
id
source:pmid:34430609
type
manuscript
label
PMID 34430609 full text
[2] object · 3 fields
id
data:geo:GSE141479
type
dataset
label
GEO GSE141479
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-34430609
type
extraction
used array · 1 item
[0]
source:pmid:34430609
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-GSE141479
type
accession_resolution
used array · 1 item
[0]
data:geo:GSE141479
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:34430609
parent_hash
sha256:269082bdcf1ec1d3f065818cf840882797737291a29344b3a0f9cf7af74bf49b
fork_of
null
gaps array · 6 items
[0]
asset:data:geo:GSE141479 licence not read
[1]
asset:data:geo:GSE141479 not downloaded
[2]
execution.not_run
[3]
review.human_critique
[4]
review.independent_reader
[5]
review.machine_critique
assays array · 1 item
[0] object · 11 fields
role
analysis
definition_id
survival_analysis
definition_version
f2132e96ae6c7a4e
required_operations array · 1 item
[0]
survival_km
support_state
supported
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
K-M survival analysis showed that high-risk NSCLC patients in the risk model had poor prognoses (Figure 9A).
order_basis
analysis_only
id
assay:1
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:34430609", "kind": "science-record", "revision": 8, "content_hash": "sha256:507929f5d639f9a6f6a1c496de4544003795ec9c1eb4e0101c32be8bf22fae05", "created_at": "2026-11-01T15:41:49Z", "updated_at": "2026-11-01T22:04:33Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Evaluation of the roles and regulatory mechanisms of PD-1 target molecules in NSCLC progression.", "doi": "10.21037/atm-21-2963", "pmid": "34430609", "authors": ["Yun-Qiang Zhang", "Ye Yuan", "Jun Zhang", "Cheng-Yi Lin", "Jia-Long Guo", "Hua-Song Liu", "Qiang Guo"], "journal": "Annals of translational medicine", "year": 2021, "abstract": "BACKGROUND: Targeted programmed cell death protein 1 (PD-1) therapy could effectively improve the long-term prognosis of patients with non-small cell lung cancer (NSCLC). The role of PD-1 targets in the progression of NSCLC has not been fully revealed.\nMETHODS: The differentially expressed genes (DEGs) in patients' blood after NSCLC treatment with PD-1 blocker nivolumab in the GSE141479 dataset were analyzed by GEO2R and identified in the TCGA database. The mechanism of action involved in the PD-1 target molecules via the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). The protein-protein interaction (PPI) network shows the relationship between PD-1 target molecules. The factors affecting the prognosis of NSCLC patients were identified via the COX regression analysis and survival analysis to build the risk model and nomogram.\nRESULTS: There were 64 DEGs in patients' blood after nivolumab treatment and 48 DEGs in NSCLC tissues. The PD-1 target molecules involved cell proliferation, DNA replication, cell cycle, lung cancer, and other cellular processes. The prognostic factors CCNA2, CHEK1, DLGAP5, E2F8, FOXM1, HIST1H2BH, HJURP, MKI67, PLK1, TPX2, and TYMS, and the independent factors HIST1H2BH and PLK1, influenced the prognosis of NSCLC patients. HIST1H2BH and PLK1 were overexpressed in LUAD and LUSC tissues. The elevated expression levels of HIST1H2BH and PLK1 were related to the overall survival (OS) and the progression-free survival of NSCLC patients. High-risk NSCLC patients had a poor prognosis and were an independent factor influencing the poor prognosis of NSCLC patients. The high-risk model group was enriched with signaling mechanisms such as cell cycle, DNA replication, and homologous recombination.\nCONCLUSIONS: The risk model based on PD-1 target molecules was helpful to assess the prognosis of NSCLC patients. HIST1H2BH and PLK1 might become prognostic biomarkers of NSCLC patients.", "claims": [{"id": "claim-method", "statement": "K-M survival analysis showed that high-risk NSCLC patients in the risk model had poor prognoses (Figure 9A).", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:34430609", "locator": "sections[21] \"Evaluation of the risk model in the prognosis of NSCLC patients\" paragraph 2", "quote": "K-M survival analysis showed that high-risk NSCLC patients in the risk model had poor prognoses (Figure 9A)."}], "state": "complete"}, {"id": "claim-data-access", "statement": "The GSE141479 dataset of the Gene Expression Omnibus [GEO (http://www.ncbi.nlm.nih.gov/geo/)] database contained gene expression data from the blood samples of 74 NSCLC patients. Among them, 33 NSCLC patients were the blood samples treated with PD-1 inhibitor nivolumab.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:34430609", "locator": "sections[3] \"GSE141479 dataset\" paragraph 2", "quote": "The GSE141479 dataset of the Gene Expression Omnibus [GEO (http://www.ncbi.nlm.nih.gov/geo/)] database contained gene expression data from the blood samples of 74 NSCLC patients. Among them, 33 NSCLC patients were the blood samples treated with PD-1 inhibitor nivolumab."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": null, "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:34430609"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE141479"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE141479"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:34430609", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.21037/atm-21-2963", "sha256": "sha256:7c09d90cca004d875918fd5659a829235d980adde13b141df4ab22040e325c11", "bytes": 36052, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.21037/atm-21-2963", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC8350711", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:GSE141479", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE141479", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE141479", "version": null, "note": "The GSE141479 dataset of the Gene Expression Omnibus [GEO (http://www.ncbi.nlm.nih.gov/geo/)] database contained gene expression data from the blood samples of 74 NSCLC patients. Among them, 33 NSCLC patients were the blood samples treated with PD-1 inhibitor nivolumab.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "The GSE141479 dataset of the Gene Expression Omnibus [GEO (http://www.ncbi.nlm.nih.gov/geo/)] database contained gene expression data from the blood samples of 74 NSCLC patients. Among them, 33 NSCLC patients were the blood samples treated with PD-1 inhibitor nivolumab.", "access_statement_kind": "repository_route_statement", "sample_accessions": ["GSM4204391", "GSM4204392", "GSM4204393", "GSM4204394", "GSM4204395", "GSM4204396", "GSM4204397", "GSM4204398", "GSM4204399", "GSM4204400", "GSM4204401", "GSM4204402", "GSM4204403", "GSM4204404", "GSM4204405", "GSM4204406", "GSM4204407", "GSM4204408", "GSM4204409", "GSM4204410", "GSM4204411", "GSM4204412", "GSM4204413", "GSM4204414", "GSM4204415", "GSM4204416", "GSM4204417", "GSM4204418", "GSM4204419", "GSM4204420", "GSM4204421", "GSM4204422", "GSM4204423", "GSM4204424", "GSM4204425", "GSM4204426", "GSM4204427", "GSM4204428", "GSM4204429", "GSM4204430", "GSM4204431", "GSM4204432", "GSM4204433", "GSM4204434", "GSM4204435", "GSM4204436", "GSM4204437", "GSM4204438", "GSM4204439", "GSM4204440", "GSM4204441", "GSM4204442", "GSM4204443", "GSM4204444", "GSM4204445", "GSM4204446", "GSM4204447", "GSM4204448", "GSM4204449", "GSM4204450", "GSM4204451", "GSM4204452", "GSM4204453", "GSM4204454", "GSM4204455", "GSM4204456", "GSM4204457", "GSM4204458", "GSM4204459", "GSM4204460", "GSM4204461", "GSM4204462", "GSM4204463", "GSM4204464"], "sample_count": 74, "group_sizes": null, "group_sizes_basis": null, "platform": "23126", "taxon": "Homo sapiens", "title": "Combination of host immune metabolic biomarkers for the PD-1 blockade cancer immunotherapy", "resolution_checked_at": "2026-11-01T15:39:54Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "asset:table:pmid:34430609:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:418f6f0db116832722a0eed0ee0675c4eff5fb0a9e96cb50a3eb48a8d93bb6eb", "bytes": 2754, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[16]/table-wrap[1]#t1", "version": null, "note": "The expression level of PD-1 target molecules in GSE141479 NSCLC blood samples", "structure": {"pmcid": "PMC8350711", "section_index": 16, "section_title": "The expression levels of PD-1 target molecules in NSCLC", "row_count": 65, "column_count": 3}, "table": {"label": "Table 1", "caption": "The expression level of PD-1 target molecules in GSE141479 NSCLC blood samples", "rows": [["Gene", "P", "logFC"], ["SNORD111", "0.00493817", "0.72559394"], ["RNU6-948P", "0.03444443", "0.69960397"], ["KCNQ1OT1_5", "0.00166819", "0.68030422"], ["LEF1-AS1", "0.03273117", "0.65527865"], ["SNORD63", "0.00920666", "0.64174079"], ["GPRASP1", "0.00110561", "0.63013588"], ["HMGB3P4", "0.00121729", "0.61194145"], ["MTCO1P31", "0.02050908", "0.60380088"], ["ARHGAP17", "0.0023222", "0.603064"], ["CUBN", "0.01017528", "0.59152504"], ["TRAJ14", "0.002776", "0.58637359"], ["CDCA2", "0.01072148", "−0.59144421"], ["FAM83D", "0.00157576", "−0.59256397"], ["FOXM1", "0.01552184", "−0.59382417"], ["H2BFS", "0.00312788", "−0.6007239"], ["KIF11", "0.01282965", "−0.60308543"], ["CENPU", "0.00655007", "−0.6075029"], ["MLC1", "0.03826616", "−0.60756707"], ["NUSAP1", "0.00545245", "−0.61177406"], ["SGOL1", "0.00965143", "−0.61373539"], ["MCM2", "0.00100469", "−0.61971768"], ["CDC6", "0.02287365", "−0.62300489"], ["KIF20A", "0.01558623", "−0.62524289"], ["GMNN", "0.00932813", "−0.6271711"], ["CENPM", "0.00565937", "−0.6351112"], ["RFC2", "0.00022004", "−0.63632544"], ["CENPN", "0.00127519", "−0.63697021"], ["BRCA2", "0.00532567", "−0.64152522"], ["E2F8", "0.03568498", "−0.64326644"], ["EXO1", "0.00176873", "−0.65220136"], ["HIST1H2BI", "0.00253962", "−0.65270249"], ["HIST1H2BJ", "0.00212488", "−0.65351784"], ["PLK1", "0.02763867", "−0.65474106"], ["DTL", "0.03959844", "−0.65616881"], ["HIST1H2BK", "0.00185741", "−0.65692162"], ["CENPF", "0.01276753", "−0.67133204"], ["CDKN3", "0.03077191", "−0.6757393"], ["HIST1H2BH", "0.0023265", "−0.67885224"], ["CKS2", "0.00375082", "−0.69673774"], ["PRRG4", "0.00719681", "−0.70325329"], ["HJURP", "0.00669842", "−0.70537786"], ["STMN1", "0.00217296", "−0.70766827"], ["PRC1", "0.00168319", "−0.7179418"], ["CCNB2", "0.03641449", "−0.71887783"], ["NDC80", "0.00073926", "−0.72614622"], ["TPX2", "0.01299743", "−0.74730387"], ["KIF15", "0.00218344", "−0.74827382"], ["HIST1H2BL", "0.00364301", "−0.7494745"], ["RAD51AP1", "0.00063054", "−0.7701625"], ["HIST1H3B", "0.00397439", "−0.78280432"], ["CCNA2", "0.02322892", "−0.79709647"], ["CD38", "0.01137765", "−0.79908712"], ["HIST1H2BB", "0.00085693", "−0.80144284"], ["HIST1H1B", "0.00378843", "−0.80473676"], ["CENPW", "0.00594784", "−0.80853294"], ["TYMS", "0.01973621", "−0.81167961"], ["TOP2A", "0.00627913", "−0.84272863"], ["HIST1H2BM", "0.01649506", "−0.88164367"], ["DLGAP5", "0.03435208", "−0.90377947"], ["CHEK1", "0.00301191", "−0.92741563"], ["MELK", "0.0003221", "−0.93779218"], ["FAM111B", "0.00026547", "−0.97286209"], ["MKI67", "0.00484638", "−0.99910995"], ["KIAA0101", "0.00937747", "−1.04596747"]], "row_count": 65, "column_count": 3, "numeric_cells": 145, "header_rows": 1, "locator": "section[16]/table-wrap[1]#t1"}}, {"id": "asset:table:pmid:34430609:2", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:751ce406af621c2334dda96ea6d76f2d93fe3631e6cc9cb917009e143ef3eb38", "bytes": 1939, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[16]/table-wrap[2]#t2", "version": null, "note": "The expression levels of PD-1 target molecules in NSCLC tissues", "structure": {"pmcid": "PMC8350711", "section_index": 16, "section_title": "The expression levels of PD-1 target molecules in NSCLC", "row_count": 49, "column_count": 3}, "table": {"label": "Table 2", "caption": "The expression levels of PD-1 target molecules in NSCLC tissues", "rows": [["Gene", "logFC", "P"], ["HIST1H3B", "6.971563358", "5.22E-42"], ["HIST1H1B", "6.889830378", "1.98E-34"], ["HIST1H2BB", "6.6176645", "2.92E-16"], ["HIST1H2BM", "6.546656387", "1.70E-27"], ["HIST1H2BI", "6.144328211", "3.81E-19"], ["HIST1H2BH", "5.25752465", "1.97E-39"], ["HJURP", "4.423193962", "9.76E-63"], ["TPX2", "4.356893524", "1.49E-61"], ["MELK", "4.28293495", "2.60E-61"], ["TOP2A", "4.239513136", "6.71E-63"], ["FOXM1", "4.206146682", "1.40E-60"], ["EXO1", "4.176032779", "4.79E-62"], ["DLGAP5", "4.123032333", "1.54E-61"], ["CENPF", "4.004101702", "2.23E-61"], ["CDC6", "3.962775113", "8.09E-62"], ["PLK1", "3.804871556", "1.14E-62"], ["CCNB2", "3.791913823", "1.42E-61"], ["HIST1H2BL", "3.771763049", "4.85E-33"], ["NDC80", "3.66052765", "1.20E-60"], ["CDCA2", "3.618670951", "2.97E-60"], ["KIF20A", "3.560206265", "2.46E-61"], ["CCNA2", "3.560063035", "9.08E-61"], ["MKI67", "3.512151918", "2.23E-58"], ["CDKN3", "3.434927857", "1.04E-57"], ["FAM83D", "3.412001161", "2.99E-50"], ["E2F8", "3.334165686", "2.05E-61"], ["PRC1", "3.322365587", "1.58E-61"], ["KIF11", "3.262694147", "7.05E-62"], ["NUSAP1", "3.233047006", "1.10E-60"], ["KIF15", "3.110763871", "7.51E-59"], ["FAM111B", "3.110199706", "4.99E-57"], ["MCM2", "2.988886147", "5.17E-58"], ["CENPU", "2.922017757", "3.96E-59"], ["RAD51AP1", "2.910137622", "4.25E-55"], ["CHEK1", "2.741114388", "2.08E-61"], ["HIST1H2BJ", "2.624552264", "7.72E-28"], ["CENPM", "2.594186936", "9.10E-51"], ["CENPW", "2.583310716", "1.63E-42"], ["DTL", "2.466385804", "3.72E-50"], ["TYMS", "2.401391345", "4.02E-56"], ["GMNN", "1.900079663", "1.15E-56"], ["CENPN", "1.899039582", "1.93E-47"], ["STMN1", "1.625279048", "2.36E-35"], ["CKS2", "1.53273206", "6.79E-34"], ["BRCA2", "1.461967704", "6.31E-37"], ["HIST1H2BK", "1.422823205", "4.16E-26"], ["RFC2", "1.239427886", "1.96E-48"], ["H2BFS", "1.214789768", "0.02134121"]], "row_count": 49, "column_count": 3, "numeric_cells": 104, "header_rows": 1, "locator": "section[16]/table-wrap[2]#t2"}}, {"id": "asset:table:pmid:34430609:3", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:9d55452b93c1081be26b57a41526dc6f68562059aac94b93e1069b8159058ab3", "bytes": 1097, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[17]/table-wrap[1]#t3", "version": null, "note": "Disease related to PD-1 target molecules", "structure": {"pmcid": "PMC8350711", "section_index": 17, "section_title": "The biological functions and signaling mechanisms of PD-1 target molecules", "row_count": 16, "column_count": 4}, "table": {"label": "Table 3", "caption": "Disease related to PD-1 target molecules", "rows": [["Category", "Term", "Count", "P"], ["GAD_DISEASE", "Breast Cancer", "10", "2.72E-05"], ["GAD_DISEASE", "Longevity", "9", "1.68E-05"], ["GAD_DISEASE", "Chronic renal failure|Kidney Failure, Chronic", "8", "0.011029875"], ["GAD_DISEASE", "Ovarian cancer", "7", "4.88E-04"], ["GAD_DISEASE", "Breast cancer", "7", "0.002764474"], ["GAD_DISEASE", "Bladder Cancer", "7", "0.003069375"], ["GAD_DISEASE", "Chronic obstructive pulmonary disease", "6", "0.005391657"], ["GAD_DISEASE", "Lung cancer", "6", "0.013295264"], ["GAD_DISEASE", "Lung Cancer", "6", "0.022918521"], ["GAD_DISEASE", "Leukemia, Lymphocytic, Chronic, B-Cell", "5", "0.002712277"], ["GAD_DISEASE", "Esophageal adenocarcinoma", "5", "0.015692824"], ["GAD_DISEASE", "Pharmacogenetic studies", "4", "0.003197262"], ["GAD_DISEASE", "Adenocarcinoma|Pancreatic Neoplasms", "3", "0.009443208"], ["GAD_DISEASE", "Head and neck cancer", "3", "0.026277742"], ["GAD_DISEASE", "Abortion, Spontaneous", "3", "0.036618707"]], "row_count": 16, "column_count": 4, "numeric_cells": 30, "header_rows": 1, "locator": "section[17]/table-wrap[1]#t3"}}, {"id": "asset:table:pmid:34430609:4", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:f316443394dda384ff62d443ad58c7d8ed955b25d2427e266d7a65de5da3acc3", "bytes": 990, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[19]/table-wrap[1]#t4", "version": null, "note": "Univariate Cox regression analysis showed the prognostic factors of NSCLC patients", "structure": {"pmcid": "PMC8350711", "section_index": 19, "section_title": "Construction of PD-1 target molecular risk model", "row_count": 12, "column_count": 5}, "table": {"label": "Table 4", "caption": "Univariate Cox regression analysis showed the prognostic factors of NSCLC patients", "rows": [["Gene", "HR", "HR.95L", "HR.95H", "P"], ["CCNA2", "1.119030214", "1.015250316", "1.233418597", "0.023527732"], ["CHEK1", "1.161268534", "1.003467151", "1.343885155", "0.044812367"], ["DLGAP5", "1.120187116", "1.007468832", "1.24551662", "0.035951079"], ["E2F8", "1.188481809", "1.015445446", "1.391004328", "0.031485368"], ["FOXM1", "1.105655354", "1.017333811", "1.20164468", "0.018052236"], ["HIST1H2BH", "0.896796742", "0.827448404", "0.971957155", "0.007986484"], ["HJURP", "1.113339724", "1.001826182", "1.237265867", "0.046168795"], ["MKI67", "1.118363726", "1.008411159", "1.24030502", "0.034124878"], ["PLK1", "1.184761851", "1.061018977", "1.322936416", "0.002592543"], ["TPX2", "1.102047152", "1.014411384", "1.19725384", "0.021538305"], ["TYMS", "1.146977658", "1.026076189", "1.282124819", "0.015825538"]], "row_count": 12, "column_count": 5, "numeric_cells": 47, "header_rows": 1, "locator": "section[19]/table-wrap[1]#t4"}}, {"id": "asset:table:pmid:34430609:5", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:3500238a2742189de98230e4635205d52276d2603ce4f62c1da1af8bc4319427", "bytes": 403, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[19]/table-wrap[2]#t5", "version": null, "note": "The independent prognostic factors of NSCLC patients", "structure": {"pmcid": "PMC8350711", "section_index": 19, "section_title": "Construction of PD-1 target molecular risk model", "row_count": 3, "column_count": 6}, "table": {"label": "Table 5", "caption": "The independent prognostic factors of NSCLC patients", "rows": [["Gene", "coef", "HR", "HR.95L", "HR.95H", "P"], ["HIST1H2BH", "−0.220239949", "0.802326258", "0.729774307", "0.882091103", "5.25E-06"], ["PLK1", "0.303398284", "1.354453815", "1.199191723", "1.529818043", "1.04E-06"]], "row_count": 3, "column_count": 6, "numeric_cells": 12, "header_rows": 1, "locator": "section[19]/table-wrap[2]#t5"}}, {"id": "asset:table:pmid:34430609:6", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:001b05e6b8c81c16c0b6330baa20e6eedfa5462362b69cb653a7da872dea8d52", "bytes": 2043, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[20]/table-wrap[1]#t6", "version": null, "note": "The value of risk model factors in LUAD", "structure": {"pmcid": "PMC8350711", "section_index": 20, "section_title": "The value of risk model factors was verified in NSCLC", "row_count": 33, "column_count": 4}, "table": {"label": "Table 6", "caption": "The value of risk model factors in LUAD", "rows": [["Clinical features", "Type", "HIST1H2BH", "PLK1"], ["Gender", "Male vs. female", "4.84E-03", "1.47E-02"], ["Age", "Age (21–40 years) vs. age (81–100 years)", "1.59E-02", "NS"], ["", "Age (41–60 years) vs. age (61–80 years)", "NS", "1.91E-02"], ["", "Age (41–60 years) vs. age (81–100 years)", "1.04E-04", "NS"], ["", "Age (61–80 years) vs. age (81–100 years)", "4.98E-03", "NS"], ["Smoking", "Non smoker vs. smoker", "4.77E-04", "1.89E-05"], ["", "Non smoker vs. reformed smoker2", "4.60E-03", "1.86E-03"], ["", "Smoker vs. reformed smoker1", "3.08E-03", "2.84E-08"], ["", "Reformed smoker1 vs. reformed smoker2", "2.58E-02", "1.50E-06"], ["Clinical stage", "Stage1 vs. Stage3", "NS", "4.15E-02"], ["", "Stage1 vs. Stage4", "NS", "9.74E-03"], ["Tissue type", "NOS vs. mixed", "7.16E-03", "2.22E-03"], ["", "NOS vs. LBC-NonMucinous", "3.45E-07", "1.10E-07"], ["", "NOS vs. LBC-Mucinous", "NS", "5.93E-10"], ["", "NOS vs. mucinous carcinoma", "2.41E-04", "2.18E-02"], ["", "NOS vs. papillary", "9.73E-07", "NS"], ["", "NOS vs. micropapillary", "7.48E-12", "NS"], ["", "Mixed vs. LBC-NonMucinous", "4.96E-03", "2.56E-03"], ["", "Mixed vs. SolidPatternPredominant", "1.84E-03", "4.67E-02"], ["", "Mixed vs. LBC-Mucinous", "NS", "2.09E-07"], ["", "Mixed vs. papillary", "1.25E-02", "NS"], ["", "Mixed vs. micropapillary", "4.82E-07", "NS"], ["", "LBC-NonMucinous vs. SolidPatternPredominant", "NS", "9.71E-05"], ["", "LBC-NonMucinous vs. acinar", "NS", "2.24E-02"], ["", "LBC-NonMucinous vs. LBC-Mucinous", "NS", "4.67E-02"], ["", "SolidPatternPredominant vs. LBC-Mucinous", "NS", "1.51E-02"], ["", "SolidPatternPredominant vs. mucinous carcinoma", "NS", "1.48E-02"], ["", "SolidPatternPredominant vs. micropapillary", "4.57E-02", "NS"], ["", "Acinar vs. LBC-Mucinous", "NS", "8.57E-04"], ["", "LBC-Mucinous vs. mucinous carcinoma", "NS", "2.79E-02"], ["", "LBC-Mucinous vs. papillary", "NS", "1.09E-02"], ["TP53 Mutant", "TP53-Mutant vs. TP53-NonMutant", "NS", "9.91E-12"]], "row_count": 33, "column_count": 4, "numeric_cells": 48, "header_rows": 1, "locator": "section[20]/table-wrap[1]#t6"}}, {"id": "asset:table:pmid:34430609:7", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:25d649a8346280f01713c9e83d5177c5b89faf6e686b053f8c38688030ffdecc", "bytes": 1030, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[20]/table-wrap[2]#t7", "version": null, "note": "The value of risk model factors in LUSC", "structure": {"pmcid": "PMC8350711", "section_index": 20, "section_title": "The value of risk model factors was verified in NSCLC", "row_count": 16, "column_count": 4}, "table": {"label": "Table 7", "caption": "The value of risk model factors in LUSC", "rows": [["Clinical features", "Type", "HIST1H2BH", "PLK1"], ["LUSC", "Normal vs. primary", "<1E-12", "<1E-12"], ["Gender", "Male vs. female", "NS", "4.31E-02"], ["Age", "Age (41–60 years) vs. age (61–80 years)", "NS", "1.41E-02"], ["", "Age (41–60 years) vs. age (81–100 years)", "NS", "2.34E-03"], ["Smoking", "Non smoker vs. smoker", "1.84E-05", "NS"], ["", "Non smoker vs. reformed smoker1", "1.04E-03", "NS"], ["", "Non smoker vs. reformed smoker2", "3.15E-06", "NS"], ["", "Smoker vs. reformed smoker1", "NS", "1.02E-02"], ["", "Reformed smoker1 vs. reformed smoker2", "NS", "3.68E-02"], ["Clinical stage", "Stage1 vs. Stage3", "NS", "2.90E-02"], ["", "Stage3 vs. Stage4", "NS", "2.70E-02"], ["", "NOS vs. papillary", "1.68E-03", "NS"], ["Lymph node metastasis", "N0 vs. N1", "NS", "6.36E-03"], ["", "N0 vs. N2", "NS", "1.32E-02"], ["TP53 Mutant", "TP53-Mutant vs. TP53-NonMutant", "NS", "2.68E-03"]], "row_count": 16, "column_count": 4, "numeric_cells": 20, "header_rows": 1, "locator": "section[20]/table-wrap[2]#t7"}}, {"id": "asset:table:pmid:34430609:8", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:0c0a44f19a3d2d66a552b0f5b5eb7bec98858f426b3cc4300d8a288e28b82f64", "bytes": 2373, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[22]/table-wrap[1]#t8", "version": null, "note": "The signaling mechanisms involved in the high-risk group", "structure": {"pmcid": "PMC8350711", "section_index": 22, "section_title": "The signaling mechanisms involved in the risk model", "row_count": 40, "column_count": 4}, "table": {"label": "Table 8", "caption": "The signaling mechanisms involved in the high-risk group", "rows": [["Name", "Size", "NES", "NOM P"], ["CELL_CYCLE", "124", "2.3562934", "0"], ["MISMATCH_REPAIR", "23", "2.2620559", "0"], ["PROGESTERONE_MEDIATED_OOCYTE_MATURATION", "85", "2.2228281", "0"], ["OOCYTE_MEIOSIS", "112", "2.2174144", "0"], ["DNA_REPLICATION", "36", "2.209795", "0"], ["ONE_CARBON_POOL_BY_FOLATE", "17", "2.2025287", "0"], ["NUCLEOTIDE_EXCISION_REPAIR", "44", "2.1026423", "0"], ["HOMOLOGOUS_RECOMBINATION", "28", "2.09409", "0"], ["PATHOGENIC_ESCHERICHIA_COLI_INFECTION", "55", "2.0320096", "0"], ["PYRIMIDINE_METABOLISM", "97", "1.9931018", "0"], ["UBIQUITIN_MEDIATED_PROTEOLYSIS", "133", "1.9535059", "0"], ["CHRONIC_MYELOID_LEUKEMIA", "73", "1.909263", "0.001972387"], ["AMINOACYL_TRNA_BIOSYNTHESIS", "22", "1.9242635", "0.001992032"], ["PANCREATIC_CANCER", "70", "1.8818412", "0.002008032"], ["BASAL_TRANSCRIPTION_FACTORS", "35", "1.8217084", "0.004008016"], ["PROTEASOME", "44", "1.9331573", "0.004040404"], ["BASE_EXCISION_REPAIR", "33", "1.8571749", "0.004166667"], ["PENTOSE_PHOSPHATE_PATHWAY", "27", "1.8049825", "0.007722008"], ["P53_SIGNALING_PATHWAY", "68", "1.7388005", "0.007843138"], ["RNA_DEGRADATION", "57", "1.7536411", "0.008"], ["SPLICEOSOME", "126", "1.7790519", "0.008064516"], ["GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM", "16", "1.7177893", "0.011904762"], ["BLADDER_CANCER", "42", "1.5846695", "0.016194332"], ["PATHWAYS_IN_CANCER", "325", "1.5147824", "0.016666668"], ["GLIOMA", "65", "1.6071352", "0.018108651"], ["CITRATE_CYCLE_TCA_CYCLE", "30", "1.7157203", "0.025590552"], ["DEGRADATION", "44", "1.6497922", "0.026859503"], ["PURINE_METABOLISM", "156", "1.5934625", "0.027139874"], ["GAP_JUNCTION", "89", "1.5358167", "0.027600849"], ["PROSTATE_CANCER", "89", "1.5185701", "0.030120483"], ["DRUG_METABOLISM_OTHER_ENZYMES", "51", "1.5393608", "0.031067962"], ["THYROID_CANCER", "29", "1.5549417", "0.032467533"], ["SMALL_CELL_LUNG_CANCER", "84", "1.5911384", "0.034836065"], ["FRUCTOSE_AND_MANNOSE_METABOLISM", "32", "1.5649511", "0.035363458"], ["NON_SMALL_CELL_LUNG_CANCER", "54", "1.5211327", "0.036885247"], ["CYSTEINE_AND_METHIONINE_METABOLISM", "34", "1.4945567", "0.03807615"], ["AMYOTROPHIC_LATERAL_SCLEROSIS_ALS", "52", "1.4684905", "0.038306452"], ["N_GLYCAN_BIOSYNTHESIS", "46", "1.5310353", "0.04761905"], ["FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS", "95", "1.5192246", "0.04897959"]], "row_count": 40, "column_count": 4, "numeric_cells": 118, "header_rows": 1, "locator": "section[22]/table-wrap[1]#t8"}}], "gaps": ["asset:data:geo:GSE141479 not downloaded", "asset:data:geo:GSE141479 licence not read"]}, "analysis": {"state": "complete", "methods": [{"id": "method-1", "family": "survival_analysis", "specific": "kaplan_meier", "label": "Survival analysis", "dsl_operations": ["survival_km"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 1.0, "band": "verbatim", "quote": "K-M survival analysis showed that high-risk NSCLC patients in the risk model had poor prognoses (Figure 9A)."}}, {"id": "method-2", "family": "survival_analysis", "specific": "cox_proportional_hazards", "label": "Survival analysis", "dsl_operations": ["cox_ph"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.7, "band": "medium", "quote": "COX regression"}}, {"id": "method-3", "family": "network_analysis", "specific": "ppi_network", "label": "Network / pathway analysis", "dsl_operations": ["build_graph", "centrality_scores", "pathway_enrich"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["edge_list"], "evidence": {"score": 0.7, "band": "medium", "quote": "protein-protein interaction"}}], "targets": [], "gaps": []}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["survival_km"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: kaplan_meier."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["GSE141479"], "resolved_accessions": ["GSE141479"], "statements": ["The GSE141479 dataset of the Gene Expression Omnibus [GEO (http://www.ncbi.nlm.nih.gov/geo/)] database contained gene expression data from the blood samples of 74 NSCLC patients. Among them, 33 NSCLC patients were the blood samples treated with PD-1 inhibitor nivolumab."], "basis": "The paper names GSE141479 in Gene Expression Omnibus (GEO) and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": ["survival_km"], "assets": ["source:pmid:34430609", "data:geo:GSE141479", "asset:table:pmid:34430609:1", "asset:table:pmid:34430609:2", "asset:table:pmid:34430609:3", "asset:table:pmid:34430609:4", "asset:table:pmid:34430609:5", "asset:table:pmid:34430609:6", "asset:table:pmid:34430609:7", "asset:table:pmid:34430609:8"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:GSE141479"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T18:33:59Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": null}, "calls": 3, "usage": {"prompt_tokens": 28823, "completion_tokens": 2330, "cached_tokens": 9736}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:34430609", "type": "paper", "label": "pmid:34430609"}, {"id": "source:pmid:34430609", "type": "manuscript", "label": "PMID 34430609 full text"}, {"id": "data:geo:GSE141479", "type": "dataset", "label": "GEO GSE141479"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:34430609", "type": "paper", "label": "pmid:34430609"}, {"id": "source:pmid:34430609", "type": "manuscript", "label": "PMID 34430609 full text"}, {"id": "data:geo:GSE141479", "type": "dataset", "label": "GEO GSE141479"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-34430609", "type": "extraction", "used": ["source:pmid:34430609"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-GSE141479", "type": "accession_resolution", "used": ["data:geo:GSE141479"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:34430609", "parent_hash": "sha256:269082bdcf1ec1d3f065818cf840882797737291a29344b3a0f9cf7af74bf49b", "fork_of": null, "generation": 7}, "gaps": ["asset:data:geo:GSE141479 licence not read", "asset:data:geo:GSE141479 not downloaded", "execution.not_run", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "analysis", "definition_id": "survival_analysis", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["survival_km"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["K-M survival analysis showed that high-risk NSCLC patients in the risk model had poor prognoses (Figure 9A)."], "order_basis": "analysis_only", "id": "assay:1"}]}